$1.4B
Surgical Robotics Funding 2026
โ 61% YoY ยท Fastest growing category
$890M
Cardiovascular Device Deals
โ 34% YoY ยท Structural heart leading
$620M
Neuromodulation Investment
โ 48% YoY ยท Closed-loop driving growth
$540M
Diabetes Device Rounds
โ 22% YoY ยท CGM + closed-loop
2026 Funding by Device Category
Surgical Robotics$1.40B
Cardiovascular Devices$890M
Neuromodulation$620M
Diabetes / Metabolic$540M
Imaging / Diagnostics HW$480M
Orthopedics / Spine$310M
Wearables / RPM$260M
Device Deal Flow (2026 Monthly)
JANFEBMARAPRMAYJUNJULAUGSEPOCTNOVDEC
52
Deals YTD
$1.9B
Deployed YTD
$36M
Avg Deal Size
Top Strategic Acquirers / Investors
6 deals ยท Surgical robotics focus
8 deals ยท Cardiac + neuro
11 deals ยท Device-focused VC
7 deals ยท Late-stage devices
Medtronic Ventures
5 deals ยท Strategic investments
Recent Device Activity
Latest funding rounds, FDA clearances, manufacturing expansions, and hiring signals
| Date | Company | Device / Technology | Event | Details | Signal |
|---|---|---|---|---|---|
| May 2 | I Sleep apnea implants ยท Golden Valley, MN |
Neurostimulation | ๐ฐ Funding | $200M Series F ยท HNS device expansion | ๐ฅ Hot |
| Apr 30 | I Venous thromboembolism ยท Irvine, CA |
Cardiovascular | ๐ฐ Funding | $185M Series E ยท ClotTriever expansion | ๐ฅ Hot |
| Apr 28 | V Surgical robotics ยท Waltham, MA |
Surgical Robotics | ๐ฐ Funding | $110M Series C ยท VR-guided laparoscopic robot | ๐ฅ Hot |
| Apr 25 | D CGM devices ยท San Diego, CA |
Diabetes Devices | ๐ FDA | G8 CGM โ 510(k) cleared. Q3 2026 commercial launch. | Watch |
| Apr 22 | S Orthopedic robotics ยท Kalamazoo, MI |
Surgical Robotics | ๐ฅ Hiring | +320 hospital placements Q1 ยท +480 roles opened | ๐ฅ Hot |
| Apr 18 | B Point-of-care ultrasound ยท Burlington, CT |
Imaging Hardware | ๐ฐ Funding | $150M Series D ยท Butterfly iQ3 global rollout | Growing |
Medical Device Funding Rounds
Companies that have raised significant capital in 2026
| Company | Device Category | Key Device | Round | Amount | Lead Investor | Date | Signal |
|---|---|---|---|---|---|---|---|
I Golden Valley, MN |
Neurostimulation | Hypoglossal Nerve Stimulator (HNS) for OSA | Series F | $200M | OrbiMed Advisors | May 2, 2026 | ๐ฅ Hot |
I Irvine, CA |
Cardiovascular | ClotTriever โ venous thromboembolism removal | Series E | $185M | Deerfield Management | Apr 30, 2026 | ๐ฅ Hot |
V Waltham, MA |
Surgical Robotics | VR-enabled single-incision laparoscopic robot | Series C | $110M | General Catalyst | Apr 28, 2026 | ๐ฅ Hot |
B Burlington, CT |
Imaging HW | Butterfly iQ3 โ pocket-sized ultrasound | Series D | $150M | Bill Gates / Fosun Pharma | Apr 18, 2026 | Growing |
B San Diego, CA |
Diabetes Devices | iLet Bionic Pancreas โ closed-loop insulin delivery | Series E | $120M | Novo Holdings | Apr 14, 2026 | ๐ฅ Hot |
N Carlsbad, CA |
Neuromodulation | Miniaturized rechargeable spinal cord stimulator | Series D | $95M | OrbiMed Advisors | Apr 10, 2026 | Growing |
S Artarmon, Australia / US |
Neuromodulation | Evoke โ world's first closed-loop SCS system | Series D | $90M | Cowen Healthcare | Apr 6, 2026 | Growing |
7 Toronto, Canada |
Spine Devices | Machine-vision image-guided spine surgery | Series C | $75M | Deerfield Management | Mar 28, 2026 | Growing |
M San Francisco, CA |
Surgical Robotics | Maestro โ collaborative laparoscopic robot | Series C | $60M | Andera Partners | Mar 22, 2026 | Growing |
S Boca Raton, FL |
Diabetes Devices | Twist โ patch insulin pump, AI dosing | Series B | $50M | Novo Holdings | Mar 15, 2026 | Watch |
E Hayward, CA |
Diagnostic Devices | PillBot โ swallowable robotic capsule endoscopy | Series B | $45M | DCVC Bio | Mar 8, 2026 | ๐ฅ Hot |
O San Jose, CA |
Renal Devices | Tablo โ home and acute hemodialysis system | Series E | $180M | OrbiMed | Feb 14, 2026 | Growing |
N Redwood City, CA |
Neuromodulation | HF10 therapy โ high-frequency SCS for chronic pain | Series D | $110M | Deerfield Management | Jan 28, 2026 | Growing |
H Clearwater, FL |
Cardiovascular | MyoVista โ AI wavECG cardiac diagnostics | Series B | $40M | Healtheon Capital | Jan 15, 2026 | Watch |
S Menlo Park, CA |
Ophthalmic Devices | OMNI Surgical System โ glaucoma canal surgery | Series D | $65M | New Enterprise Associates | Jan 8, 2026 | Growing |
Manufacturing & Infrastructure Buildouts
Device manufacturers expanding production capacity, clean rooms, and device assembly lines
B
Medical devices ยท Marlborough, MA
Cardiac Device Manufacturing Campus โ Clonmel, Ireland
$500M ยท 1,800 jobs ยท EU hub for cardiac rhythm management and electrophysiology devices. ISO 13485 certified clean rooms. Targeting 40% of European CRM demand by 2028.
Foundation and steel structure complete
Class 100K clean room shell installation
HVAC, utilities, and clean room fit-out (Q4 2026)
FDA/CE validation and first device build (2027)
M
Surgical robotics ยท Memphis, TN
Hugo RAS Global Manufacturing Center
$340M ยท Memphis, TN ยท Assembles Hugo robotic-assisted surgery systems at scale. ISO Class 7 clean rooms. Targeting 500 units/year by 2027. Competing with Intuitive Surgical's Da Vinci fleet.
Facility construction complete
Robotic assembly line tooling installed
Quality management system validation
Full production ramp (Q1 2027)
D
CGM devices ยท Mesa, AZ
G8 CGM High-Volume Manufacturing โ Mesa, Arizona
$280M expansion ยท Mesa AZ campus ยท Dedicated G8 sensor production lines with automated assembly and inspection. Targeting 50M+ sensors/year to support G8 global commercial launch in Q3 2026.
Building expansion complete
Automated assembly line installed and qualified
Process validation (PPQ) complete
FDA pre-market inspection prep underway
Commercial launch production (Q3 2026)
S
Surgical + ortho robotics ยท Portage, MI
MAKO SmartRobotics Assembly Center Expansion
$220M ยท Portage, MI + Mahwah, NJ ยท Doubles MAKO robot production capacity. Q1 2026 saw 320 new hospital placements โ demand is outpacing supply. Expansion targets 800 system/year cadence.
Additional assembly bays constructed
Robotic assembly fixtures being installed
Equipment qualification and first article (Q3 2026)
Full ramp to 800 units/year (Q1 2027)
I
Wearable insulin pumps ยท Acton, MA
OmniPod 6 High-Volume Pod Manufacturing โ Acton, MA
$175M buildout ยท Automated fill-finish pod assembly ยท OmniPod 5 closed-loop success drove massive demand. Expansion for OmniPod 6 pre-commercial builds and 2027 launch capacity planning.
Facility shell and clean room construct
Automated dispensing equipment installed
Process validation ongoing
Commercial scale production (Q4 2026)
V
Surgical robotics ยท Waltham, MA
Robot Assembly and Sterilization Facility โ Waltham, MA
$95M buildout ยท In-house robot assembly + sterilizable instrument production. $110M Series C funding (Apr 2026) earmarked for facility completion and pre-IDE submissions to FDA for surgical robotic system.
Lease signed, buildout permits obtained
Clean room shell construction underway
Robot assembly cell installation (Q3 2026)
First 510(k) submission robot builds (Q1 2027)
Heavy Hiring in Medical Devices
Companies with large open role counts โ a clear signal of growth stage and investment priority
I
Da Vinci robotic systems ยท Sunnyvale, CA
Robotics Systems Engineer380 roles
Clinical Sales Representative290 roles
Regulatory Affairs Specialist185 roles
Manufacturing Process Eng160 roles
Software / Embedded Eng210 roles
M
Diversified medical devices ยท Dublin, Ireland
Product Development Engineer480 roles
Quality Systems Manager320 roles
Clinical Field Specialist410 roles
Manufacturing Engineer360 roles
Hugo Robot Service Eng180 roles
S
Orthopedic + surgical devices ยท Portage, MI
MAKO Sales Representative480 roles
Robotics Service Engineer320 roles
Orthopedic Clinical Specialist420 roles
Product R&D Engineer280 roles
Quality Engineer180 roles
D
CGM devices ยท San Diego, CA
Sensor Bioelectronics Eng180 roles
Connected Device SW Eng145 roles
Regulatory Affairs Manager95 roles
Mfg Process Engineer120 roles
CGM Clinical Specialist90 roles
I
Sleep apnea implants ยท Golden Valley, MN
Therapy Account Manager160 roles
Clinical Training Specialist95 roles
Implant Device Engineer75 roles
Regulatory Affairs Assoc60 roles
Quality Systems Engineer50 roles
I
VTE devices ยท Irvine, CA
Interventional Sales Specialist110 roles
Clinical R&D Engineer72 roles
Manufacturing Engineer58 roles
Regulatory Affairs Assoc45 roles
Field Clinical Educator35 roles
B
Point-of-care ultrasound ยท Burlington, CT
Ultrasound Hardware Engineer72 roles
Embedded SW / Firmware Eng58 roles
International Sales Director45 roles
Clinical Education Specialist38 roles
RA / Quality Engineer27 roles
B
Diagnostics + devices ยท Franklin Lakes, NJ
Diagnostics Assay Developer320 roles
Manufacturing Technician380 roles
Regulatory Affairs Manager220 roles
Field Service Engineer180 roles
Product R&D Engineer190 roles
Regulatory Pipeline Tracker
510(k) clearances, PMA approvals, CE marks, and IDE studies โ active 2026 submissions
| Company | Device | Category | Pathway | Status | Indication | Est. Decision |
|---|---|---|---|---|---|---|
| G8 CGM System | Diabetes | 510(k) | โ Cleared Apr 25 | Real-time continuous glucose monitoring, 15-day wear | Cleared | |
| Surgical Robot System v2 | Surgical Robotics | 510(k) | โณ Under Review | Soft tissue laparoscopic procedures | Q4 2026 | |
| Nalu SCS System Gen 3 | Neuromodulation | PMA Suppl. | โณ Under Review | Chronic intractable back and leg pain | Q3 2026 | |
| Evoke Closed-Loop SCS | Neuromodulation | PMA | โณ Pre-submission | Closed-loop spinal cord stimulation for pain | Q1 2027 | |
| Butterfly iQ3 AI Ultrasound | Imaging | 510(k) | โ Cleared Mar 2026 | Whole-body point-of-care imaging, AI-guided views | Cleared | |
| Hugo RAS System โ US Clearance | Surgical Robotics | 510(k) | โณ Under Review | Soft tissue robotic-assisted surgery (US market) | Q2 2026 | |
I Inspire Medical |
Inspire System Gen 5 | Neurostimulation | PMA Suppl. | โณ Under Review | HNS โ expanded age indication, pediatric OSA | Q3 2026 |
| PillBot Robotic Capsule | Diagnostic Devices | De Novo | โณ Pre-submission | Swallowable remotely controlled capsule endoscopy | 2027 | |
| iLet Bionic Pancreas v2 | Diabetes | PMA Suppl. | โณ Under Review | Closed-loop insulin + glucagon dual-hormone delivery | Q4 2026 | |
| Flash Navigation Platform | Spine Devices | 510(k) | โ Cleared Feb 2026 | Machine-vision 3D navigation for spine surgery | Cleared | |
| OMNI Surgical System 2.0 | Ophthalmology | 510(k) | โณ Under Review | Canal-based MIGS for mild-to-moderate glaucoma | Q2 2026 | |
| Maestro Robotic Assistant | Surgical Robotics | CE Mark | โ CE Mark Q1 2026 | Laparoscopic surgical assistant โ EU commercial launch | Cleared (EU) |